一个突变的伴侣将野生类型的蛋白质转化为瘤特异性抗原
Andrea Schietinger1, Mary Philip, Barbara A Yoshida
1Department of Pathology, Committee on Immunology, Committee on Cancer Biology, University of Chicago, Chicago, IL 60637, USA. aschieti@uchicago.edu
概括
研究人员发现了一种方法,可以为癌症治疗创造瘤特异性点. 一种突变产生了一种独特的糖类新表位,导致具有抗瘤作用的特定单克隆抗体.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 葡萄糖生物学 葡萄糖生物学
背景情况:
- 单克隆抗体是癌症治疗的关键药物.
- 细胞内瘤抗原限制了抗体的可访问性.
- 需要新的策略来有效地准癌症.
研究的目的:
- 研究将野生类型蛋白质转化为瘤特异性抗原的潜力.
- 探索创建用于治疗向的新型葡萄糖基新表位物.
主要方法:
- 在陪伴基因Cosmc.中诱导了体质突变.
- 破坏了O-甘氨酸核1合成.
- 产生了一种瘤特异的糖性新表位.
主要成果:
- 一种野生类型的跨膜蛋白被转化为瘤特异性抗原.
- 创建了一个新型的糖性新表位.
- 这种表位引起了具有抗瘤活性的高亲和度,特异性单克隆抗体.
结论:
- 从野生类型的蛋白质可以产生瘤特异的糖性新表位.
- 这些新表位是癌症单克隆抗体治疗的可行标.
- 这种方法为开发向癌症治疗提供了新的途径.
相关概念视频
Mutations
Overview
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Mutations
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Forced Transdifferentiation
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...
Artificial transdifferentiation occurs...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


